Aurinia Pharmaceuticals Inc (STU:IKAP)
€ 9.252 -0.386 (-4%) Market Cap: 1.32 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 3.57 GF Score: 84/100

Q1 2021 Aurinia Pharmaceuticals Inc Earnings Call Transcript

May 06, 2021 / 09:00PM GMT
Release Date Price: €9.99 (-2.02%)
Operator

Good afternoon, ladies and gentlemen, and welcome to Aurinia Pharmaceuticals First Quarter 2021 Financial Results Conference event. (Operator Instructions)

It is now my pleasure to turn the floor over to your host, Glenn Schulman. Sir, the floor is yours.

Glenn Schulman
Aurinia Pharmaceuticals Inc. - SVP of Corporate Communications & IR

Thanks, Matthew, and good afternoon, everyone. I'm pleased to welcome you to today's call discussing Aurinia's first quarter financial results. Joining me on the call this afternoon are Peter Greenleaf, our President and CEO; Max Colao, Chief Commercial Officer; Neil Solomons, Chief Medical Officer; and Joe Miller, our Chief Financial Officer.

This afternoon, after the close, we issued a press release announcing our financial results and recent operational highlights, which is accessible from our website at www.auriniapharma.com, and has been filed on Form 8-K with the SEC as well. We also filed our financial statement and management's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot